632
Views
8
CrossRef citations to date
0
Altmetric
Laboratory Study

Renal Microvascular Injury in Chronic Aristolochic Acid Nephropathy and Protective Effects of Cozaar

, , , , , , , , , & show all
Pages 60-67 | Received 06 Apr 2011, Accepted 04 Sep 2011, Published online: 29 Nov 2011

REFERENCES

  • Sun D, Feng JM, Dai C, . Influence of hypoxia caused by impairment of peritubular capillary on the progression of chronic aristolochic acid nephropathy. Zhonghua Yi Xue Za Zhi. 2006;86(21):1464–1469.
  • Sun D, Liu CX, Ma YY, Zhang L. Protective effect of prostaglandin e1 on renal microvascular injury in rats of acute aristolochic acid nephropathy. Ren Fail. 2011;33(2):225–232.
  • Wen YJ, Qu L, Li XM. Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury. Transl Res. 2008;152(1):38–46.
  • Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia. 2000;43:1205–1223.
  • Wu X, Liu N. The role of Ang/Tie signaling in lymphangiogenesis. Lymphology. 2010;43(2):59–72.
  • Thomas M, Augustin HG. The role of the angiopoietins in vascular morphogenesis. Angiogenesis. 2009;12(2):125–137.
  • Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312(5):630–641.
  • Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol. 2010;25(3):387–396.
  • Yancopoulos GD, Davis S, GaleN W, . Vascular-specific growth factors and blood vessel formation. Nature. 2000;407(6801):242–248.
  • Holash J, Maisonpierre PC, Compton D, . Vessel cooption, regression,, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284(5422):1994–1998.
  • Kang DH, Anderson S, Kim YG, . Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis. 2001;37(3):601–611.
  • Civin CI, Strauss LC, Brovall C, . Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1acells. J Immunol. 1984;133:157–165.
  • Schoell WM, Pieber D, Reich O, . Tumor angiogenesis as a prognostic factor in ovarian carcinoma: Quantification of endothelial immunoreactivity by image analysis. Cancer. 1997;80:2257–2262.
  • Sun D, Sun L, Wang W, . Effects of ginkgo biloba extract on peritubular capillaries in rats of aristolochic acid nephropathy. Zhong Guo Xian Dai Yi Xue Za Zhi. 2006;16(3):346–350, 353.
  • Zeisberg M, Shah AA, Kalluri R. Bonemorphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. Biol Chem. 2005;280(9):8094–8100.
  • Tumane RG, Pingle SK, Jawade AA, Nath NN. An overview of caspase: Apoptotic protein for silicosis. Indian J Occup Environ Med. 2010;14(2):31–38.
  • Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351(1–2):41–58.
  • Kazama I, Mahoney Z, Miner JH, Graf D, Economides AN, Kreidberg JA. Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol. 2008;19(11):2181–2191.
  • Xu YF, Wan JX, Jiang DW. Effects of bone morphogenic protein-7 on transdifferentiation and the expression of connective tissue growth factor of human renal tubular epithelial cells induced by transforming growth factor-beta1. Zhonghua Yi Xue Za Zhi. 2009;89(23):1639–1644.
  • Dudas PL, Argentieri RL, Farrell FX. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant. 2009;24(5):1406–1416.
  • Negri AL. Prevention of progressive fibrosis in chronic renal diseases: Antifibroticagents. J Nephrol. 2004;17(4):496–503.
  • Dube PH, Almanzar MM, Frazier KS. Osteogenic protein-1: Gene expression and treatment in rat remnant kidney model. Toxicol Pathol. 2004;32(4):384–392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.